Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

AbD Serotec provides anti-idiotype antibodies as tools for research and development

May 19, 2010

Amorfix and Epitomics agreement to develop mAbs for treatment of cancer

May 12, 2010

NexACT technology shown to enhance bioavailability of rituximab in preclinical study

May 11, 2010

Evotec and Genentech enter agreement to discover small-molecule therapeutics

May 11, 2010

Polyphor enters into PEMfinder collaboration with Novartis

May 10, 2010

Intercell acquires monoclonal antibody discovery platform from Cytos

May 10, 2010

Bicycle Therapeutics signs license agreement with EPFL in Switzerland

May 4, 2010

New FDA initiative to reduce risks related to infusion pumps

April 27, 2010

Genentech and Seattle Genetics to renew antibody-drug conjugate collaboration

April 22, 2010

Silence Therapeutics and AstraZeneca extend siRNA delivery collaboration

April 22, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...